{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:47:17Z","timestamp":1762325237726,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 63-year-old woman presented with abdominal pain and hematochezia was referred for <jats:sup>18<\/jats:sup>F-FDG PET\/CT for the underlying malignancy. PET\/CT detected diffuse thickening of the bowel walls with intense radioactivity in the colons. She was later diagnosed with multiple myeloma and secondary gastrointestinal amyloidosis, and achieved complete response of myeloma and amyloidosis after 9 cycles of chemotherapy. This case highlighted that gastrointestinal abnormality caused by amyloidosis might be the only presenting symptoms and findings in <jats:sup>18<\/jats:sup>F-FDG PET\/CT in patients with multiple myeloma.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004092","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T17:51:46Z","timestamp":1645638706000},"page":"721-722","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Secondary Gastrointestinal Amyloidosis With Increased 18F-FDG Uptake as the Only Presentation in a Patient With Multiple Myeloma"],"prefix":"10.1097","volume":"47","author":[{"given":"Jie","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixue","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bmt.1705395","article-title":"Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?","volume":"38","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1572-0241.2007.01669.x","article-title":"Gastrointestinal manifestations of amyloidosis","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3324\/haematol.2012.068155","article-title":"Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience","volume":"98","year":"2013","journal-title":"Haematologica"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1365-2036.2008.03682.x","article-title":"Review article: gastrointestinal amyloidosis\u2014clinical features, diagnosis and therapy","volume":"27","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/13506129.2012.682833","article-title":"18F-FDG PET\/CT in patients with amyloid light-chain amyloidosis: case-series and literature review","volume":"19","year":"2012","journal-title":"Amyloid"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00259-013-2375-1","article-title":"Utility of 18F-FDG PET(\/CT) in patients with systemic and localized amyloidosis","volume":"40","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20250621","first-page":"145","article-title":"18F-FDG imaging: pitfalls and artifacts","volume":"33","year":"2005","journal-title":"J Nucl Med Technol"},{"key":"bib8-20250621","first-page":"622501","article-title":"PET\/CT in multiple myeloma: beyond FDG","volume":"10","year":"2020","journal-title":"Front Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:01:30Z","timestamp":1750536090000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004092","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,2,21]]}}}